2019 Q3 Form 10-Q Financial Statement

#000156459020051388 Filed on November 05, 2020

View on sec.gov

Income Statement

Concept 2019 Q3
Revenue $31.36K
YoY Change -70.0%
Cost Of Revenue $137.6K
YoY Change -14.01%
Gross Profit -$106.2K
YoY Change 77.03%
Gross Profit Margin -338.72%
Selling, General & Admin $344.5K
YoY Change -21.71%
% of Gross Profit
Research & Development $458.6K
YoY Change -2.43%
% of Gross Profit
Depreciation & Amortization $460.00
YoY Change
% of Gross Profit
Operating Expenses $862.4K
YoY Change -12.89%
Operating Profit -$992.2K
YoY Change -5.5%
Interest Expense $15.76K
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.006M
YoY Change -4.95%
Income Tax
% Of Pretax Income
Net Earnings -$1.006M
YoY Change -4.95%
Net Earnings / Revenue -3209.6%
Basic Earnings Per Share -$0.04
Diluted Earnings Per Share -$0.04
COMMON SHARES
Basic Shares Outstanding 27.08M
Diluted Shares Outstanding 27.08M

Balance Sheet

Concept 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.188M
YoY Change 166.73%
Cash & Equivalents $4.188M
Short-Term Investments
Other Short-Term Assets $1.649M
YoY Change 199.77%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $5.836M
YoY Change 175.3%
LONG-TERM ASSETS
Property, Plant & Equipment $5.839K
YoY Change -99.99%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.383M
YoY Change -17.68%
Total Long-Term Assets $48.44M
YoY Change -4.17%
TOTAL ASSETS
Total Short-Term Assets $5.836M
Total Long-Term Assets $48.44M
Total Assets $54.28M
YoY Change 3.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $784.5K
YoY Change 45.27%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $881.8K
YoY Change 37.77%
LONG-TERM LIABILITIES
Long-Term Debt $5.204M
YoY Change
Other Long-Term Liabilities $866.3K
YoY Change -4.8%
Total Long-Term Liabilities $6.071M
YoY Change 567.12%
TOTAL LIABILITIES
Total Short-Term Liabilities $881.8K
Total Long-Term Liabilities $6.071M
Total Liabilities $6.953M
YoY Change 345.67%
SHAREHOLDERS EQUITY
Retained Earnings -$48.71M
YoY Change
Common Stock $96.03M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $47.33M
YoY Change
Total Liabilities & Shareholders Equity $54.28M
YoY Change 3.06%

Cashflow Statement

Concept 2019 Q3
OPERATING ACTIVITIES
Net Income -$1.006M
YoY Change -4.95%
Depreciation, Depletion And Amortization $460.00
YoY Change
Cash From Operating Activities -$1.478M
YoY Change -10.03%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.202M
YoY Change 78.68%
NET CHANGE
Cash From Operating Activities -1.478M
Cash From Investing Activities 0.000
Cash From Financing Activities 5.202M
Net Change In Cash 3.724M
YoY Change 193.56%
FREE CASH FLOW
Cash From Operating Activities -$1.478M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 us-gaap Professional Fees
ProfessionalFees
44452
CY2020 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
976144
CY2020 pzg Stock Issued During Period Value Payment Of Interest Accrued
StockIssuedDuringPeriodValuePaymentOfInterestAccrued
119309
CY2020 pzg Stock Issued During Period Value Private Placement
StockIssuedDuringPeriodValuePrivatePlacement
4882966
CY2020Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
255941
CY2020Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
30942
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
77424
CY2020Q3 pzg Stock Issued During Period Value Payment Of Interest Accrued
StockIssuedDuringPeriodValuePaymentOfInterestAccrued
205413
CY2020Q3 us-gaap Exploration Expense
ExplorationExpense
636027
CY2020Q3 pzg Land Holding Costs
LandHoldingCosts
131183
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1224
CY2020Q3 pzg Interest And Service Charges
InterestAndServiceCharges
123685
CY2020Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
279345
CY2020Q3 pzg Stock Issued During Period Value Conversion Of Debt
StockIssuedDuringPeriodValueConversionOfDebt
192066
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1331508
CY2019Q3 us-gaap Profit Loss
ProfitLoss
-1006499
CY2019Q3 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
976144
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
28310
CY2020Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
17384
CY2019Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2645
CY2020Q3 pzg Interest Expense Income
InterestExpenseIncome
100674
CY2019Q3 pzg Interest Expense Income
InterestExpenseIncome
15758
CY2020Q3 pzg Interest Earned On Reclamation Bond
InterestEarnedOnReclamationBond
1224
CY2019Q3 pzg Interest Earned On Reclamation Bond
InterestEarnedOnReclamationBond
6790
CY2020Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-312162
CY2020Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1713117
CY2019Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1477910
CY2019Q3 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
5201807
CY2020Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
770514
CY2019Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5201807
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-942603
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3723897
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5434081
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
463690
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4491478
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4187587
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.51
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.64
CY2020 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
278181
CY2020Q3 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
475949
CY2020Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
460939
CY2020Q3 us-gaap Accretion Expense
AccretionExpense
15010
CY2019Q3 us-gaap Accretion Expense
AccretionExpense
23647
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
5288
CY2020Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
16474
CY2020Q3 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
183395
CY2020Q2 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
183395
CY2019Q3 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1096791
CY2019Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.89
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
943992

Files In Submission

Name View Source Status
0001564590-20-051388-index-headers.html Edgar Link pending
0001564590-20-051388-index.html Edgar Link pending
0001564590-20-051388.txt Edgar Link pending
0001564590-20-051388-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
pzg-10q_20200930.htm Edgar Link pending
pzg-20200930.xml Edgar Link completed
pzg-20200930.xsd Edgar Link pending
pzg-20200930_cal.xml Edgar Link unprocessable
pzg-20200930_def.xml Edgar Link unprocessable
pzg-20200930_lab.xml Edgar Link unprocessable
pzg-20200930_pre.xml Edgar Link unprocessable
pzg-ex311_7.htm Edgar Link pending
pzg-ex312_9.htm Edgar Link pending
pzg-ex321_6.htm Edgar Link pending
pzg-ex322_8.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending